Trends and Development in the Antibiotic-Resistance of Acinetobacter baumannii: A Scientometric Research Study (1991–2019)

References

• Wendt C, Dietze B, Dietz E, Rüden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35(6):1394–1397. doi:10.1128/JCM.35.6.1394-1397.19979163451
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–951. doi:10.1038/nrmicro178918007677
   PubMed Web of Science ®Google Scholar
• Villegas V, Hartstein AI. Acinetobacter outbreaks, 1977–2000. Infecti Control Hospital Epidemiol. 2003;24(4):284–295. doi:10.1086/502205
   Web of Science ®Google Scholar
• Fournier PE, R H, Weinstein RA. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–699. doi:10.1086/50020216447117
   PubMed Web of Science ®Google Scholar
• Falagas ME, Bliziotis IA. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents. 2007;29(6):630–636. doi:10.1016/j.ijantimicag.2006.12.01217306965
   PubMed Web of Science ®Google Scholar
• Gootz TD, M A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther. 2008;6(3):309–325. doi:10.1586/14787210.6.3.30918588496
   PubMed Web of Science ®Google Scholar
• Liu C, Chang Y, Xu Y, et al. Acinetobacter baumannii distribution of virulence-associated genes and antimicrobial susceptibility in clinical isolates. Oncotarget. 2018;9(31):21663–21673. doi:10.18632/oncotarget.2465129774093
   PubMedGoogle Scholar
• Cerqueira GM, Peleg AY. Insights into Acinetobacter baumannii pathogenicity. IUBMB Life. 2011;63(12):1055–1060. doi:10.1002/iub.53321989983
   PubMed Web of Science ®Google Scholar
• Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1–12. doi:10.1086/59501119035777
   PubMed Web of Science ®Google Scholar
• G E, H W, H-B J, RR I. Envelope determinants that control drug resistance, virulence, and surface variability. Annu Rev Microbiol. 2019;undefined(undefined):undefined.
   Google Scholar
• Chang Y, Luan G, Ying X, et al. Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital. Front Microbiol. 6:910.26388854
   PubMed Web of Science ®Google Scholar
• Getchell-White SI, Donowitz LG, Gröschel DH. The inanimate environment of an intensive care unit as a potential source of nosocomial bacteria: evidence for long survival of Acinetobacter calcoaceticus.. Infecti Control Hospital Epidemiol. 1989;10(9):402–407. doi:10.1086/646061
   Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582.18625687
   PubMed Web of Science ®Google Scholar
• Upadhyay S, Khyriem A, Bhattacharyya P, Joshi S. Acinetobacter baumanniiHigh-level aminoglycoside resistance in recovered from intensive care unit patients in Northeastern India. Indian J Med Microbiol. 2018;36(1):43–48. doi:10.4103/ijmm.IJMM_17_22529735825
   PubMed Web of Science ®Google Scholar
• Kwon NY, Kim JD, Pai HJ. The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii. Korean J Intern Med. 2002;17(2):94–99. doi:10.3904/kjim.2002.17.2.9412164097
   PubMedGoogle Scholar
• Arvaniti K, Lathyris D, Ruimy R, et al. The importance of colonization pressure in multiresistant Acinetobacter baumannii acquisition in a Greek intensive care unit. Critical Care (London, England). 2012;16(3):R102. doi:10.1186/cc11383
   PubMed Web of Science ®Google Scholar
• Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004;101(Suppl 1):5303–5310. doi:10.1073/pnas.030751310014724295
   PubMed Web of Science ®Google Scholar
• Chen C, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: a scientometric update (2000-2014). Expert Opin Biol Ther. 2014;14(9):1295–1317. doi:10.1517/14712598.2014.92081325077605
   PubMed Web of Science ®Google Scholar
• G S, L W, X Y, et al. Bibliometric and visualized analysis of stem cells therapy for spinal cord injury based on web of science and CiteSpace in the last 20 years. World Neurosurg. 2019;132:e246–e258. doi:10.1016/j.wneu.2019.08.19131493613
   PubMed Web of Science ®Google Scholar
• Chen C, Ibekwesanjuan F, Hou J. The structure and dynamics of co-citation clusters: a multiple-perspective co-citation analysis. J Am Soc Inf Sci Technol. 2014;61(7):1386–1409. doi:10.1002/asi.21309
   Web of Science ®Google Scholar
• Wu M, Wang Y, Yan C, Zhao Y. viaStudy on subclinical hypothyroidism in pregnancy: a bibliometric analysis CiteSpace. J Mater Fetal Neonatal Med. 2020;1–12.
   Web of Science ®Google Scholar
• Chen S, Bie R, Lai Y, Shi H, Ung COL, Hu H. Trends and development in enteral nutrition application for ventilator associated pneumonia: a scientometric research study (1996-2018). Front Pharmacol. 2019;10:246. doi:10.3389/fphar.2019.0024630949050
   PubMed Web of Science ®Google Scholar
• Chen C, Chen Y, Horowitz M, Hou H, Liu Z, Pellegrino D. Towards an explanatory and computational theory of scientific discovery ☆. J Informetr. 2009;3(3):191–209. doi:10.1016/j.joi.2009.03.004
   Web of Science ®Google Scholar
• Xiao F, Li C, Sun J, Zhang L. Knowledge domain and emerging trends in organic photovoltaic technology: a scientometric review based on CiteSpace analysis. Front Chem. 2017;5:67. doi:10.3389/fchem.2017.0006728966923
   PubMed Web of Science ®Google Scholar
• Reyes-Gonzalez L, Gonzalez-Brambila CN, Veloso F. Using co-authorship and citation analysis to identify research groups: a new way to assess performance. Scientometrics. 2016;108(3):1171–1191. doi:10.1007/s11192-016-2029-8
   Web of Science ®Google Scholar
• Magiorakos A-P, S A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Arakawa Y, Murakami M, Suzuki K, et al. A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother. 1995;39(7):1612–1615. doi:10.1128/AAC.39.7.16127492116
   PubMed Web of Science ®Google Scholar
• Zhou H, Tan W, Qiu Z, Song Y, Gao S. A bibliometric analysis in gene research of myocardial infarction from 2001 to 2015. PeerJ. 2018;6:e4354. doi:10.7717/peerj.435429456889
   PubMed Web of Science ®Google Scholar
• Liang YD, Li Y, Zhao J, Wang XY, Zhu HZ, Chen XH. Study of acupuncture for low back pain in recent 20 years: a bibliometric analysis via CiteSpace. J Pain Res. 2017;10:951–964. doi:10.2147/JPR.S13280828479858
   PubMed Web of Science ®Google Scholar
• R Z, C Y, J Y, et al. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents. 2013;42(4):322–328. doi:10.1016/j.ijantimicag.2013.06.01923988720
   PubMed Web of Science ®Google Scholar
• Monserrat-Martinez A, Gambin Y, Sierecki E. Thinking outside the bug: molecular targets and strategies to overcome antibiotic resistance. Int J Mol Sci. 2019;20:6.
   Web of Science ®Google Scholar
• Guo W, Guo SC, Li M, Li LH, Qu Y. Acinetobacter baumannii successful treatment of extensively drug-resistant ventriculitis with polymyxin B and tigecycline- a case report. Antimicrob Resist Infect Control. 2018;7(22).
   Google Scholar
• Vrancianu CO, Gheorghe I, Czobor IB, Chifiriuc MC. Acinetobacter baumannii antibiotic resistance profiles, molecular mechanisms and innovative treatment strategies of. Microorganisms. 2020;8:6.
   Web of Science ®Google Scholar
• G Z, B O, Pace DG. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. J Infect Dev Ctries. 2014;8(2):129–136. doi:10.3855/jidc.357324518621
   PubMed Web of Science ®Google Scholar
• R K, Dinan TG, Cryan JF. The microbiome: a key regulator of stress and neuroinflammation. Neurobiology of Stress. 2016;4:23–33. doi:10.1016/j.ynstr.2016.03.00127981187
   PubMedGoogle Scholar
• Turner D, Wand ME, Briers Y, Lavigne R, Sutton JM, Reynolds DM. Characterisation and genome sequence of the lytic Acinetobacter baumannii bacteriophage vB_AbaS_Loki. PLoS One. 2017;12(2):e0172303. doi:10.1371/journal.pone.017230328207864
   PubMed Web of Science ®Google Scholar
• Modi SR, Lee HH, Spina S, Collins JJ. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature. 2013;499(7457):219–222. doi:10.1038/nature1221223748443
   PubMed Web of Science ®Google Scholar
• Q P, Colomer-Lluch M, Martínez-Castillo A, et al. Antibiotic resistance genes in the bacteriophage DNA fraction of human fecal samples. Antimicrob Agents Chemother. 2014;58(1):606–609. doi:10.1128/AAC.01684-1324165177
   PubMed Web of Science ®Google Scholar
• Kusradze I, Karumidze N, Rigvava S, et al. Characterization and testing the efficiency of phage as an antibacterial agent. Front Microbiol. 2016;7(undefined):1590.27757110
   PubMed Web of Science ®Google Scholar
• Grygorcewicz B, Roszak M, Golec P, et al. Acinetobacter baumannii antibiotics Act with vB_AbaP_AGC01 phage against in human heat-inactivated plasma blood and models. Int J Mol Sci. 2020;21:12.
   Web of Science ®Google Scholar
• Y H, L L, L S, J S. Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol. 2010;10(undefined):131. doi:10.1186/1471-2180-10-13120426877
   PubMed Web of Science ®Google Scholar
• Lin DM, K B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017;8(3):162–173. doi:10.4292/wjgpt.v8.i3.16228828194
   PubMedGoogle Scholar
• Chmielarczyk A, Higgins PG, Wojkowska-Mach J, et al. Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide. J Hosp Infect. 2012;81(4):239–245. doi:10.1016/j.jhin.2012.05.01022727825
   PubMed Web of Science ®Google Scholar
• Nagarajan D, Roy N, Kulkarni O, et al. Ω76: a designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant. Sci Advan. 2019;5(7):eaax1946. doi:10.1126/sciadv.aax194631355341
   PubMed Web of Science ®Google Scholar
• P N, Proietti MF, Cecchini L, et al. Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. Clin Microbiol Infect. 2005;11(8):682–683. doi:10.1111/j.1469-0691.2005.01198.x16008625
   PubMed Web of Science ®Google Scholar
• Wang J, Wong W, Whitley JC, et al. Ancient antimicrobial peptides kill antibiotic-resistant pathogens: Australian mammals provide new options. PLoS One. 2011;6(8):e24030. doi:10.1371/journal.pone.002403021912615
   PubMed Web of Science ®Google Scholar
• Falanga A, Lombardi L, Franci G, et al. Marine antimicrobial peptides: nature provides templates for the design of novel compounds against pathogenic bacteria. Int J Mol Sci. 2016;17:5.
   Web of Science ®Google Scholar
• Wang Y, Wang Z, Chen Y, et al. A highly efficient crispr-cas9-based genome engineering platform in Acinetobacter baumannii to understand the HO-sensing mechanism of OxyR. Cell Chem Biol. 2019;26(12):1732–1742.e1735. doi:10.1016/j.chembiol.2019.09.00331548010
   PubMed Web of Science ®Google Scholar
• Salter SJ, Scott P, Page AJ, et al. Acinetobacter baumannii pangenome of uncovers two groups of genomes, one of them with genes involved in CRISPR/Cas defence systems associated with the absence of plasmids and exclusive genes for biofilm formation. Microbial Genomics. 2019;5:11. doi:10.1099/mgen.0.000247
   Web of Science ®Google Scholar
• AP AP, TC V, T J, S K, K L, Prabhakar Kodali V. Acinetobacter in silico sgRNA tool design for CRISPR control of quorum sensing in species. Genes Dis. 2018;5(2):123–129. doi:10.1016/j.gendis.2018.03.00430258941
   PubMed Web of Science ®Google Scholar
• Eze E, Chenia H, El Zowalaty ME. Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. <![CDATA[Infection and Drug Resistance]]>. 2018;11:2277–2299. doi:10.2147/IDR.S16989430532562
   PubMed Web of Science ®Google Scholar
• Sun J, G Y, Scarlat MM, L G, Yang X-G, Hu Y-C. Bibliometric study of the orthopaedic publications from China. Int Orthop. 2018;42(3):461–468. doi:10.1007/s00264-018-3828-829464369
   PubMed Web of Science ®Google Scholar